On-topic pages from domain.
title / url | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
2012 Safety Alerts for Human Medical Products http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u | 2.15 | 0.93 | 0.85 | 193 | 47 | 0 | 0 | 0 | 0 | |
FDA Reinforces Commitment to Drug Safety http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108833.htm | 0.15 | 0.94 | 0.85 | 47 | 4 | 0 | 0 | 0 | 0 | |
FDA Drug Safety Podcast: Update on the risk for serious bleeding events with the anticoagulant Pradaxa http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm326863.htm | 0.16 | 0.64 | 0.72 | 54 | 11 | 0 | 0 | 0 | 0 | |
OxySure Portable Emergency Oxygen System, Model 615 by OxySure Therapeutics, Inc: FDA Safety Communication - Do Not Use http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/u | 0.15 | 0.75 | 0.95 | 59 | 13 | 0 | 0 | 0 | 0 | |
Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/u | 0.18 | 0.94 | 0.93 | 60 | 14 | 0 | 0 | 1 | 2 | |
October 2015 http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm471840.htm | 0.16 | 0.91 | 0.9 | 83 | 14 | 0 | 0 | 0 | 0 | |
FDA's Sentinel Initiative - Background http://www.fda.gov/Safety/FDAsSentinelInitiative/ucm149340.htm | 0.16 | 0.73 | 0.68 | 58 | 6 | 0 | 0 | 0 | 0 | |
Drug Safety Priorities 2016: Initiatives and Innovation http://www.fda.gov/Drugs/DrugSafety/ucm522941.htm | 0.16 | 0.92 | 0.83 | 110 | 29 | 3 | 3 | 0 | 0 | |
Postmarketing Safety Evaluation of New Molecular Entities: Final Report http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders | 0.19 | 0.95 | 0.88 | 61 | 14 | 1 | 1 | 0 | 0 | |
FDA's Sentinel Initiative http://www.fda.gov/Safety/FDAsSentinelInitiative/ | 0.21 | 0.93 | 0.78 | 65 | 10 | 1 | 1 | 0 | 0 |